Making Decentralized Clinical Trials For Rare Disease Patients Commonplace
Source: MRN - Medical Research Network
By Caroline Potts, MRN
While clinical trials can be a critical key in “unlocking the gate” to the next stages of ongoing care and treatment, understanding the journey of the rare disease patient and family can provide invaluable perspectives in the development of the trial protocol, as well as its implementation. The philosophy that rare disease patients are individuals with families and lives — and not subjects — should inform every aspect of the trial.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader